Intra-arterial administration of methotrexate, Adriamycin, and cisplatin as neoadjuvant chemotherapy for bladder cancer Manabu KuriyamaYoshito TakahashiYukimichi Kawada Session I: Local Administration Intra-Arterial Injection Pages: S1 - S4
Intra-arterial adriamycin chemotherapy in combination with radiotherapy for advanced bladder cancer Yoshiteru SumiyoshiTakeshi UyamaSusumu Kagawa Session I: Local Administration Intra-Arterial Injection Pages: S5 - S9
The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin Yosuke MatsumuraHideyuki Akazathe Japanese Urological Cancer Research Group for Adriamycin Intravesical Instillation I. Prophylactic Therapy Pages: S10 - S14
Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese urological cancer research group for Adriamycin Hideyuki AkazaKenkichi KoisoThe Japanese Urological Cancer Research Group for Adriamycin Intravesical Instillation I. Prophylactic Therapy Pages: S15 - S20
Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results Masaki TogashiNobuo ShinoharaThe Hokkaido University Bladder Cancer Collaborating Group Intravesical Instillation I. Prophylactic Therapy Pages: S21 - S25
A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer-intravesical thio-TEPA versus oral UFT Yoshihiko HiraoEigoro OkajimaYoshio Maruyama Intravesical Instillation I. Prophylactic Therapy Pages: S26 - S30
Adjuvant chemotherapy with early intravesical instillation of Adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer Toyofumi UedaSeiji Naitothe Kyushu University Urological Oncology Group Intravesical Instillation I. Prophylactic Therapy Pages: S31 - S36
Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response Iwao FukuiKazunori KiharaHiroyuki Oshima Intravesical Instillation II. Ablative Therapy Pages: S37 - S40
Sequential instillation therapy with mitomycin C and Adriamycin for superficial bladder cancer Shigeo IsakaTatsuya OkanoJun Shimazaki Intravesical Instillation II. Ablative Therapy Pages: S41 - S44
Intravesical instillation of Adriamycin for bladder tumors Hiroshi OheHiroki WatanabeShuichi Nakagawa OriginalPaper Pages: S45 - S49
Intravesical instillation of Adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study Yoshitada OhiHiroyuki OhmoriYasuo Ohashi Intravesical Instillation II. Ablative Therapy Pages: S50 - S54
Results of adjuvant chemotherapy for invasive uroepithelial cancer Yasunari UekadoAtsuyuki HiranoTadashi Ohkawa Session II: Systemic Administration Combination Chemotherapy (I) Pages: S55 - S58
Combination chemotherapy for advanced urothelial-tract carcinoma Masafumi SahashiYoshinari OnoMasanori Fukushima Session II: Systemic Administration Combination Chemotherapy (I) Pages: S59 - S62
Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer Sumio NoguchiYoshinobu KubotaMasahiko Hosaka Session II: Systemic Administration Combination Chemotherapy (I) Pages: S63 - S65
Clinical and pathological evaluations of methotrexate, vinblastine, Adriamycin and cisplatin chemotherapy for advanced urothelial cancers Takayoshi OgawaAkinobu GotohSadao Kamidono Session II: Systemic Administration Combination Chemotherapy (I) Pages: S66 - S71
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced urothelial cancer Osamu UekiHaruo HisazumiToshiaki Sugata Combination Chemotherapy (II) Pages: S72 - S76
Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, Adriamycin, and cisplatin Mikio IgawaTaisuke OhkuchiTsuguru Usui Combination Chemotherapy (II) Pages: S77 - S80
Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract — a preliminary report Ming-Huei LeeM. T. ChenP. M. Chen Combination Chemotherapy (II) Pages: S81 - S84
Evaluation of systemic chemotherapy with methotrexate, vinblastine, Adriamycin, and cisplatin for advanced bladder cancer Toshihiko KotakeHideyuki AkazaThe Japanese Urological Cancer Research Group for Adriamycin Combination Chemotherapy (II) Pages: S85 - S89
The use of adriamycin and its derivatives in the treatment of prostatic cancer D. W. W. Newling Session III: State of the Art in Urinary Tract Tumors Pages: S90 - S94
Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group A. P. M. van der MeijdenKarl-Heinz KurthMembers of the EORTC Genito-Urinary Group Session III: State of the Art in Urinary Tract Tumors Pages: S95 - S98
Chemotherapy of advanced transitional-cell carcinoma of the bladder Robert S. MillerFrank M. Torti Session III: State of the Art in Urinary Tract Tumors Pages: S99 - S110
